AG Mednet CEO Abraham Gutman recently shared the story of his entrepreneurial journey with a well-known and highly-respected healthcare IT journalist. The conversation gave him an opportunity to walk down memory lane and discuss the dramatic changes AG Mednet went through from its original business concept to where it is today.

1. AG MEDNET, led by Abraham Gutman, has created a solution
to improve the quality and efficiency of imaging-based clinical trials.

2. A NOTE FROM THE CEO
Recently I had the pleasure to speak with Sramana Mitra, a
well-known and highly-respected journalist in the technology
and healthcare IT space. Sramana asked questions about the
development and history of AG Mednet which gave me a chance
to walk down memory lane. I shared my story about moving from
telecommunications to clinical trials and the dramatic changes AG
Mednet went through from our original business concept to where
we are today.
If you would like to read my conversation with Sramana, you can
view the full Q&A. And if you would like to see how AG Mednet
came to be, please turn to the next slide...
{
Abraham Gutman
CEO, AG Mednet

3. THE BIG
BUSINESS PROBLEM:
E VEN THOUGH THERE WAS
HIGH DEMAND FOR ACQUIRING
MEDICAL IMAGES...
THE EARLY YEARS{

4. THE IMAGE FILE SIZES WERE BIG
AND COMPLEX TO MOVE.
THE EARLY YEARS{

5. RADIOLOGISTS WERE AVAILABLE,
BUT IN THE WRONG
PLACE.
THE EARLY YEARS{

6. “I CAN SOLVE THIS PROBLEM.
I COME FROM TELECOMMUNICATIONS
WHERE WE CREATED THE ABILITY TO
MOVE LOTS OF INFORMATION FROM
ONE PLACE TO OTHERS.”
THE EUREKA MOMENT{

7. TESTING THE CONCEPT
I got in my car and started going to hospitals in New England.
{

8. I asked them if they had
a radiology problem.
They all thought it was a
TRICK QUESTION.
“WE DON’T HAVE A RADIOLOGIST AND IT’S A BIG PROBLEM.”
THEY SAID,
TESTING THE CONCEPT{

9. IT WAS VERY IMPORTANT TO BE ABLE
TO BUILD SOMETHING THAT WOULD
ALLOW THESE IMAGES TO GO IN
AND OUT OF THE HOSPITAL WITH
MINIMAL OR NO IT INTERVENTION.
THE BRAINCHILD{

10. Can you move images in
support of clinical trials?”
THE PHONE CALL
A DOCTOR AT BRIGHAM AND
WOMEN’S HOSPITAL SAID,
“I understand you are moving imagesfor our radiology department.
{

11. “WHAT IS A CLINICAL TRIAL?”
I SAID
THE PHONE CALL{

12. He said, “We need to move these phenomenally large images. You
shouldn’t worry about what a clinical trial is. CAN YOU MOVE THESE
IMAGES FOR US?”
GO TIME
we were deployed at the top 15 hospitals
in the United States.
I SAID, “YES.”
{

13. My business plan had TWO CHAPTERS. Each one had only one page.
BUSINESS PLAN
One page said hope
and the other said luck.
{

14. As we continued development,
GlaxoSmithKline learned about
what we were doing.
THE FIRST CUSTOMER
Luck struck.
{

15. They gave us a call and said,
They became our first customer.
We’re about to start a very big clinical trial. It’s
global. We’re going to have 300 sites. We’re going
to be deployed in 30 countries and we cannot
collect CDs so we need to use what you have.
THE FIRST CUSTOMER{

16. We developed a functionality that CHECKS THE QUALITY of
the data at the source versus checking the quality after the
data had arrived at the laboratories.
REVOLUTIONIZING QUALITY{

17. Checking the QUALITY at
the source makes all the sense in
the world but that had NEVER
HAPPENED in clinical trials.
REVOLUTIONIZING QUALITY{

18. WE ENSURE THAT THERE ARE NO DISCREPANCIES.
WHEN THERE ARE DISCREPANCIES,
THERE’S A QUERY PROCESS. THAT
PROCESS OF QUERYING BACK AND FORTH
CAN DELAY A TRIAL BY SEVEN WEEKS.
{ IMPROVING EFFICIENCY

19. WE ARE ABLE TO CHECK FOR
DISCREPANCIES PRIOR TO
THE IMAGES BEING SENT,
IN
IMAGING TRIALS.
MORE THAN
WHICH REDUCES THE NUMBER
OF QUERIES BY
{ IMPROVING EFFICIENCY

20. IT TAKES 10 YEARS
TO TAKE A DRUG FROM
CONCEPT TO SUBMISSION
AND COSTS MORE THAN
A BILLION DOLLARS.
GAME-CHANGING IMPACT{

21. THE PATENT IS FOR
20 YEARSBUT THE CLOCK BEGINS TICKING
WHEN THE FIRST TRIAL BEGINS.
GAME-CHANGING IMPACT{

22. THOSE 10 YEARS
of clinical trials are eating
away at your patent.
GAME-CHANGING IMPACT{

23. {There must be ways to reduce
or slow down the growing
cost of clinical trials.
A BILLION DOLLARS IN 10 YEARS IS UNACCEPTABLE.

24. AG Mednet, providing clinical trial quality support
to 30,000 investigator sites in 70 countries at
the world’s top 20 pharmaceutical, biotech and
medical device companies since 2007. Helping
make Zero-Delay Clinical Trials a reality.

25. Learn how AG Mednet can help turn these alarming numbers around and how it’s helping
improve the quality and efficiency of imaging-based clinical trials at www.agmednet.com.
Do you have questions or comments about the AG Mednet story? Connect with AG
Mednet team on LinkedIn or Twitter.